DNA methylation changes at TREM2 intron 1 and TREM2 mRNA expression in patients with Alzheimer's disease

Journal of Psychiatric Research

Volumn 92, Issue , 2017, Pages 74-80

  Ozaki, Yuki ^a   Yoshino, Yuta ^a   Yamazaki, Kiyohiro ^a   Sao, Tomoko ^a   Mori, Yoko ^a   Ochi, Shinichiro ^a   Yoshida, Taku ^a   Mori, Takaaki ^a   Iga, Jun ichi ^a   Ueno, Shu ichi ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; TREM2 PROTEIN, HUMAN;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DISCRIMINANT ANALYSIS; DNA METHYLATION; FEMALE; GENE EXPRESSION; HUMAN; INTRON; LEUKOCYTE; MALE; PRIORITY JOURNAL; CASE CONTROL STUDY; GENETICS; METABOLISM; RECEIVER OPERATING CHARACTERISTIC; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE EXPRESSION; HUMANS; INTRONS; MALE; MEMBRANE GLYCOPROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; ROC CURVE;

EID: 85017356633     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2017.04.003     Document Type: Article

References (45)

1. Abdolmaleky, H.M., Smith, C.L., Faraone, S.V., Shafa, R., Stone, W., Glatt, S.J., Tsuang, M.T., Methylomics in psychiatry: modulation of gene-environment interactions may be through DNA methylation. Am. J. Med. Genet. B Neuropsychiatr. Genet. 127B:1 (2004), 51–59.
2. Balmer, D., LaSalle, J.M., Clonal maintenance of imprinted expression of SNRPN and IPW in normal lymphocytes: correlation with allele-specific methylation of SNRPN intron 1 but not intron 7. Hum. Gene 108:2 (2001), 116–122.
3. Carrol, E.D., Salway, F., Pepper, S.D., Saunders, E., Mankhambo, L.A., Ollier, W.E., Hart, C.A., Day, P., Successful downstream application of the Paxgene Blood RNA system from small blood samples in paediatric patients for quantitative PCR analysis. BMC Immunol., 8, 2007, 20.
4. Castellani, R.J., Rolston, R.K., Smith, M.A., Alzheimer disease. Dis. Mon. 56:9 (2010), 484–546.
5. Celarain, N., Sánchez-Ruiz de Gordoa, J., Zelaya, M.V., Roldán, M., Larumbe, R., Pulido, L., Echavarri, C., Mendioroz, M., TREM2 upregulation correlates with 5-hydroxymethycytosine enrichment in Alzheimer's disease hippocampus. Clin. Epigenetics, 8, 2016, 37.
6. Cummings, J.L., Ihl, R., Herrschaft, H., Hoerr, R., Tribanek, M., Sensitivity to change of composite and frequency scores of the Neuropsychiatric Inventory in mild to moderate dementia. Int. Psychogeriatr. 25:3 (2013), 431–438.
7. Davies, M.N., Volta, M., Pidsley, R., Lunnon, K., Dixit, A., Lovestone, S., Coarfa, C., Harris, R.A., Milosavljevic, A., Troakes, C., Al-Sarraj, S., Dobson, R., Schalkwyk, L.C., Mill, J., Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol., 13(6), 2012.
8. De Strooper, B., Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process. Physiol. Rev. 90:2 (2010), 465–494.
9. Dick, K.J., Nelson, C.P., Tsaprouni, L., Sandling, J.K., Aïssi, D., Wahl, S., Meduri, E., Morange PE7 Gagnon, F., Grallert, H., Waldenberger, M., Peters, A., Erdmann, J., Hengstenberg, C., Cambien, F., Goodall, A.H., Ouwehand, W.H., Schunkert, H., Thompson, J.R., Spector, T.D., Gieger, C., Trégouët, D.A., Deloukas, P., Samani, N.J., DNA methylation and body-mass index: a genome-wide analysis. Lancet 383:9933 (2014), 1990–1998.
10. El-Maarri, O., Becker, T., Junen, J., Manzoor, S.S., Diaz-Lacava, A., Schwaab, R., Wienker, T., Oldenburg, J., Gender specific differences in levels of DNA methylation at selected loci from human total blood: a tendency toward higher methylation levels in males. Hum. Genet. 122:5 (2007), 505–514.
11. Folstein, M.F., Folstein, S.E., McHugh, P.R., Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:3 (1975), 189–198.
12. Fraga, M.F., Ballestar, E., Paz, M.F., Ropero, S., Setien, F., Ballestar, M.L., Heine-Suñer, D., Cigudosa, J.C., Urioste, M., Benitez, J., Boix-Chornet, M., Sanchez-Aguilera, A., Ling, C., Carlsson, E., Poulsen, P., Vaag, A., Stephan, Z., Spector, T.D., Wu, Y.Z., Plass, C., Esteller, M., Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. U. S. A. 102:30 (2005), 10604–10609.
13. Funahashi, Y., Yoshino, Y., Yamazaki, K., Mori, Y., Mori, T., Ozaki, Y., Sao, T., Ochi, S., Iga, J-I., Ueno, S-I., DNA methylation changes at SNCA intron 1 in patients with dementia with Lewy bodies. Psychiatr. Clin. Neurosci. 71 (2017), 28–35.
14. Godler, D.E., Slater, H.R., Bui, Q.M., Ono, M., Gehling, F., Francis, D., Amor, D.J., Hopper, J.L., Hagerman, R., Loesch, D.Z., FMR1 intron 1 methylation predicts FMRP expression in blood of female carriers of expanded FMR1 alleles. J. Mol. Diagn 13:5 (2011), 528–536.
15. Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J.S., Younkin, S., Hazrati, L., Collinge, J., Pocock, J., Lashley, T., Williams, J., Lambert, J.C., Amouyel, P., Goate, A., Rademakers, R., Morgan, K., Powell, J., St George-Hyslop, P., Singleton, A., Hardy, J., TREM2 variants in Alzheimer's disease. N. Engl. J. Med. 368:2 (2013), 117–127.
16. Hardy, J.A., Higgins, G.A., Alzheimer's disease: the amyloid cascade hypothesis. Science 256:5054 (1992), 184–185.
17. Hsieh, C.L., Koike, M., Spusta, S.C., Niemi, E.C., Yenari, M., Nakamura, M.C., Seaman, W.E., A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. J. Neurochem. 109:4 (2009), 1144–1156.
18. Hu, N., Tan, M.S., Yu, J.T., Sun, L., Tan, L., Wang, Y.L., Jiang, T., Tan, L., Increased expression of TREM2 in peripheral blood of Alzheimer's disease patients. J. Alzheimers Dis. 38:3 (2014), 497–501.
19. Hughes, C.P., Berg, L., Danziger, W.L., Coben, L.A., Martin, R.L., A new clinical scale for the staging of dementia. Br. J. Psychiatry 140 (1982), 566–572.
20. Jay, T.R., Miller, C.M., Cheng, P.J., Graham, L.C., Bemiller, S., Broihier, M.L., Xu, G., Margevicius, D., Karlo, J.C., Sousa, G.L., Cotleur, A.C., Butovsky, O., Bekris, L., Staugaitis, S.M., Leverenz, J.B., Pimplikar, S.W., Landreth, G.E., Howell, G.R., Ransohoff, R.M., Lamb, B.T., TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models. J. Exp. Med. 212 (2015), 287–295.
21. Jonsson, T., Stefansson, K., TREM2 and neurodegenerative disease. N. Engl. J. Med. 369:16 (2013), 1568–1569.
22. Labbé, C., Lorenzo-Betancor, O., Ross, O.A., Epigenetic regulation in Parkinson's disease. Acta Neuropathol. 132:4 (2016), 515–530.
23. Lee, K.W., Pausova, Z., Cigarette smoking and DNA methylation. Front. Genet., 4, 2013, 132.
24. Li, H., Guo, Z., Guo, Y., Li, M., Yan, H., Cheng, J., Wang, C., Hong, G., Common DNA methylation alterations of Alzheimer's disease and aging in peripheral whole blood. Oncotarget 7 (2016), 19089–19098.
25. Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:4 (2001), 402–408.
26. Lue, L.F., Schmitz, C.T., Serrano, G., Sue, L.I., Beach, T.G., Walker, D.G., TREM2 protein expression changes correlate with Alzheimer's disease neurodegenerative pathologies in post-mortem temporal cortices. Brain Pathol. 25:4 (2015), 469–480.
27. Mohs, R.C., Rosen, W.G., Davis, K.L., The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy. Psychopharmacol. Bull. 19:3 (1983), 448–450.
28. Mori, Y., Yoshino, Y., Ochi, S., Yamazaki, K., Kawabe, K., Abe, M., Kitano, T., Ozaki, Y., Yoshida, T., Numata, S., Mori, T., Iga, J., Kuroda, N., Ohmori, T., Ueno, S., TREM2 mRNA expression in leukocytes is increased in Alzheimer's disease and schizophrenia. PLoS One, 10(9), 2015.
29. N'Diaye, E.N., Branda, C.S., Branda, S.S., Nevarez, L., Colonna, M., Lowell, C., Hamerman, J.A., Seaman, W.E., TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria. J. Cell Biol. 184:2 (2009), 215–223.
30. Neumann, H., Takahashi, K., Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis. J. Neuroimmunol. 184:1–2 (2007), 92–99.
31. Paloneva, J., Mandelin, J., Kiialainen, A., Bohling, T., Prudlo, J., Hakola, P., Haltia, M., Konttinen, Y.T., Peltonen, L., DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features. J. Exp. Med. 198:4 (2003), 669–675.
32. Prince, M., Wimo, A., Guerchet, M., Gemma-Claire, A., Yu-Tzu, W., Matthew, P., World Alzheimer Report 2015. The Global Impact of Dementia. An Analysis of Prevalence, Incidence, Cost and Tends., 2015 (London, UK).
33. Smith, A.R., Smith, R.G., Condliffe, D., Hannon, E., Schalkwyk, L., Mill, J., Lunnon, K., Increased DNA methylation near TREM2 is consistently seen in the superior temporal gyrus in Alzheimer's disease brain. Neurobiol. Aging 47 (2016), 35–40.
34. Tanzi, R.E., The synaptic Abeta hypothesis of Alzheimer disease. Nat. Neurosci. 8:8 (2005), 977–979.
35. Wan, E.S., Qiu, W., Carey, V.J., Morrow, J., Bacherman, H., Foreman, M.G., Hokanson, J.E., Bowler, R.P., Crapo, J.D., DeMeo, D.L., Smoking-associated site-specific differential methylation in buccal mucosa in the COPDGene study. Am. J. Respir. Cell Mol. Biol. 53:2 (2015), 246–254.
36. Wang, Y., Cella, M., Mallinson, K., Ulrich, J.D., Young, K.L., Robinette, M.L., Gilfillan, S., Krishnan, G.M., Sudhakar, S., Zinselmeyer, B.H., Holtzman, D.M., Cirrito, J.R., Colonna, TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell 160:6 (2015), 1061–1071.
37. Watanabe, S.Y., Iga, J., Ishii, K., Numata, S., Shimodera, S., Fujita, H., Ohmori, T., Biological tests for major depressive disorder that involve leukocyte gene expression assays. J. Psychiatr. Res. 66–67 (2015), 1–6.
38. Wockner, L.F., Noble, E.P., Lawford, B.R., Young, R.M., Morris, C.P., Whitehall, V.L., Voisey, J., Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients. Transl. Psychiatry, 4, 2014, e339.
39. Xue, Q., Xu, Y., Yang, H., Zhang, L., Shang, J., Zeng, C., Yin, P., Bulun, S.E., Methylation of a novel CpG island of intron 1 is associated with steroidogenic factor 1 expression in endometriotic stromal cells. Reprod. Sci. 21:3 (2014), 395–400.
40. Yamazaki, K., Yoshino, Y., Mori, T., Okita, M., Yoshida, T., Mori, Y., Ozaki, Y., Sao, T., Iga, J., Ueno, S., Association study and meta-analysis of polymorphisms, methylation profiles, and peripheral mRNA expression of the serotonin transporter gene in patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 41:5–6 (2016), 334–347.
41. Yoshino, Y., Kawabe, K., Yamazaki, K., Watanabe, S., Numata, S., Mori, Y., Yoshida, T., Iga, J., Ohmori, T., Ueno, S., Elevated TREM2 mRNA expression in leukocytes in schizophrenia but not major depressive disorder. J. Neural Transm. (Vienna) 123:6 (2016), 637–641.
42. Yoshino, Y., Kawabe, K., Mori, T., Mori, Y., Yamazaki, K., Numata, S., Nakata, S., Yoshida, T., Iga, J., Ohmori, T., Ueno, S., Low methylation rates of dopamine receptor D2 gene promoter sites in Japanese schizophrenia subjects. World J. Biol. Psychiatry 17:6 (2016), 449–456.
43. Yoshino, Y., Mori, T., Yoshida, T., Yamazaki, K., Ozaki, Y., Sao, T., Funahashi, Y., Iga, J., Ueno, S., Elevated mRNA expression and low methylation of SNCA in Japanese Alzheimer's disease subjects. J. Alzheimers Dis., 54(4), 2016.
44. Zenaro, E., Pietronigro, E., Della Bianca, V., Piacentino, G., Marongiu, L., Budui, S., Turano, E., Rossi, B., Angiari, S., Dusi, S., Montresor, A., Carlucci, T., Nanì, S., Tosadori, G., Calciano, L., Catalucci, D., Berton, G., Bonetti, B., Constantin, G., Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin. Nat. Med. 21:8 (2015), 880–886.
45. Zenaro, E., Piacentino, G., Constantin, G., The blood-brain barrier in Alzheimer's disease. Neurobiol. Dis., 2016.